THESEUS PHARMACEUTICALS, INC. Capital Expenditures
THESEUS PHARMACEUTICALS, INC. reported Capital Expenditures of $61.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2023-11-17
- THESEUS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $50.00K, a 20.63% decline year-over-year.
- THESEUS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $11.00K, a 96.89% decline year-over-year.
- THESEUS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- THESEUS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $11.00K.
- THESEUS PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $455.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2023-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $61.00K derived: sum of 2 quarters · filed 2023-11-17 | $61.00K 10-Q · filed 2023-11-17 | $72.00K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $11.00K 10-Q · filed 2023-08-10 | $22.00K derived: sum of 3 quarters · filed 2023-08-10 | $85.00K derived: sum of 4 quarters · filed 2023-11-17 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $11.00K derived: sum of 2 quarters · filed 2023-05-11 | $74.00K derived: sum of 3 quarters · filed 2023-11-17 | $428.00K derived: sum of 4 quarters · filed 2023-11-17 |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $74.00K derived: sum of 2 quarters · filed 2023-11-17 | $428.00K derived: sum of 3 quarters · filed 2023-11-17 | $455.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $417.00K derived: sum of 2 quarters · filed 2023-11-17 | $444.00K 10-Q · filed 2023-11-17 | |
| 2022-06-30 | $354.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $381.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $27.00K 10-Q · filed 2023-05-11 |